Steven Cohen Biogen Inc. Transaction History

Point72 Asset Management, L.P.

$51 Billion
Q3 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Biogen Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 3,872,901 shares of BIIB stock, worth $649 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

3,872,901

Previous 3,831,727 1.07%

Holding current value

$649 Million

Previous $481 Million 12.74%

% of portfolio

1.06%

Previous 1.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$122.68 - $148.84 $5.05 Million - $6.13 Million	41,174 Added 1.07%	3,872,901 $543 Million
Q2 2025 Aug 14, 2025	BUY	$113.38 - $135.49 $388 Million - $464 Million	3,424,470 Added 840.86%	3,831,727 $481 Million
Q1 2025 May 15, 2025	BUY	$133.43 - $153.27 $54.3 Million - $62.4 Million	407,257 New	407,257 $55.7 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $146 Million - $165 Million	-577,541 Reduced 92.31%	48,100 $12.4 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $19.1 Million - $22.1 Million	-69,472 Reduced 9.99%	625,641 $178 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $136 Million - $155 Million	-531,011 Reduced 43.31%	695,113 $193 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $114 Million - $139 Million	-451,858 Reduced 26.93%	1,226,124 $340 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $238 Million - $328 Million	1,222,182 Added 268.14%	1,677,982 $448 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $67.5 Million - $80.3 Million	360,000 Added 375.78%	455,800 $93 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $99.9 Million - $126 Million	-515,700 Reduced 84.33%	95,800 $20.2 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $130 Million - $167 Million	580,648 Added 1882.04%	611,500 $147 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $60.7 Million - $79.2 Million	-214,654 Reduced 87.43%	30,852 $8.73 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $33.7 Million - $54 Million	130,106 Added 112.74%	245,506 $85 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $20.3 Million - $23.7 Million	-83,360 Reduced 41.94%	115,400 $32.3 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $19.6 Million - $29.5 Million	82,817 Added 71.43%	198,760 $48.7 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $16.4 Million - $18.9 Million	61,862 Added 114.39%	115,943 $32.9 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $11.9 Million - $16.4 Million	54,081 New	54,081 $16 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $7.58 Million - $11.9 Million	-35,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $2.09 Million - $2.65 Million	-7,500 Reduced 17.65%	35,000 $10.5 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $30.4 Million - $39.7 Million	-103,500 Reduced 70.89%	42,500 $15 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $76.9 Million - $91.6 Million	-298,615 Reduced 67.16%	146,000 $42.4 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $50 Million - $70.7 Million	192,296 Added 76.21%	444,615 $122 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $78.6 Million - $88.1 Million	-255,603 Reduced 50.32%	252,319 $80.4 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $143 Million - $167 Million	507,922	507,922 $159 Million

Others Institutions Holding BIIB

# of Institutions

1,073

Shares Held

131M

Call Options Held

3.82M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $24.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account